In cancer cells, the excessive activation of PARPs significantly increases the catabolism of NAD+, resulting in a concomitant rise in NAM levels and a reduction in NAD+ concentrations, which may markedly reduce the deacetylase activity of SIRT1 [63]. This evidence concerns the gene SIRT1 and cancer.